Dual Antiplatelet Therapy and Heparin “Bridging” Significantly Increase the Risk of Bleeding Complications After Pacemaker or Implantable Cardioverter-Defibrillator Device Implantation
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
- Boston Scientific Corporation
This publication has 20 references indexed in Scilit:
- From Randomized Controlled Trials to Observational StudiesThe American Journal of Medicine, 2009
- Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guideJournal of Thrombosis and Haemostasis, 2008
- Mechanisms of Thrombus FormationNew England Journal of Medicine, 2008
- ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial InfarctionJACC, 2007
- Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic DiseaseCirculation, 2007
- Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery StentsJACC, 2007
- Acute Clopidogrel Use and Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass SurgeryJACC, 2006
- The mechanism of action of aspirinThrombosis Research, 2003
- Implantation of Pacemakers and Implantable Cardioverter Defibrillators in Orally Anticoagulated PatientsPacing and Clinical Electrophysiology, 2003
- Management of Anticoagulation before and after Elective SurgeryNew England Journal of Medicine, 1997